Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 239 | 4 | 231 | 122 | 119 |
| Receivables | 392 | 295 | 166 | 317 | 292 |
| Inventories | 666 | 686 | 1,387 | 1,356 | 1,361 |
| TOTAL | $1,555 | $1,243 | $2,002 | $2,022 | $1,956 |
| Non-Current Assets | |||||
| PPE Net | 100 | 103 | 112 | 102 | 104 |
| Investments And Advances | 72 | 64 | 52 | 61 | 79 |
| Intangibles | 296 | 317 | 361 | 361 | 382 |
| Other Non-Current Assets | 192 | 282 | 314 | 342 | 369 |
| TOTAL | $659 | $766 | $838 | $865 | $934 |
| Total Assets | $2,214 | $2,010 | $2,840 | $2,887 | $2,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,559 | 20,098 | 18,830 | 17,592 | 15,797 |
| Accounts payable and accrued liabilities | 769 | 637 | 608 | 553 | 665 |
| Accrued Expenses | 2,723 | 2,665 | 2,658 | 2,395 | 2,304 |
| Other current liabilities | N/A | 10,804 | 9,929 | 9,036 | 8,305 |
| TOTAL | $34,402 | $34,404 | $32,294 | $29,746 | $27,253 |
| Non-Current Liabilities | |||||
| Long Term Debt | 164 | 150 | 150 | 150 | 150 |
| Deferred Revenues | 476 | 58 | 127 | 32 | 46 |
| Other Non-Current Liabilities | 90 | 140 | 172 | 203 | 233 |
| TOTAL | $261 | $292 | $322 | $353 | $386 |
| Total Liabilities | $34,663 | $34,696 | $32,616 | $30,099 | $27,638 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,773 | 15,868 | 11,068 | 9,074 | 8,788 |
| Common Shares | 181 | 137 | 122 | 107 | 102 |
| Retained earnings | -141,116 | -133,826 | -128,936 | -124,042 | -120,694 |
| Other shareholders' equity | 32,058 | 31,997 | 31,997 | 31,976 | 31,976 |
| TOTAL | $-32,449 | $-32,686 | $-29,776 | $-27,212 | $-24,748 |
| Total Liabilities And Equity | $2,214 | $2,010 | $2,840 | $2,887 | $2,890 |